457 related articles for article (PubMed ID: 8205619)
1. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
Thierfelder L; Watkins H; MacRae C; Lamas R; McKenna W; Vosberg HP; Seidman JG; Seidman CE
Cell; 1994 Jun; 77(5):701-12. PubMed ID: 8205619
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.
Watkins H; Conner D; Thierfelder L; Jarcho JA; MacRae C; McKenna WJ; Maron BJ; Seidman JG; Seidman CE
Nat Genet; 1995 Dec; 11(4):434-7. PubMed ID: 7493025
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.
Watkins H; McKenna WJ; Thierfelder L; Suk HJ; Anan R; O'Donoghue A; Spirito P; Matsumori A; Moravec CS; Seidman JG
N Engl J Med; 1995 Apr; 332(16):1058-64. PubMed ID: 7898523
[TBL] [Abstract][Full Text] [Related]
4. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.
Watkins H; MacRae C; Thierfelder L; Chou YH; Frenneaux M; McKenna W; Seidman JG; Seidman CE
Nat Genet; 1993 Apr; 3(4):333-7. PubMed ID: 7981753
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.
Coviello DA; Maron BJ; Spirito P; Watkins H; Vosberg HP; Thierfelder L; Schoen FJ; Seidman JG; Seidman CE
J Am Coll Cardiol; 1997 Mar; 29(3):635-40. PubMed ID: 9060904
[TBL] [Abstract][Full Text] [Related]
6. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy.
Watkins H; Seidman JG; Seidman CE
Hum Mol Genet; 1995; 4 Spec No():1721-7. PubMed ID: 8541871
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy.
Bonne G; Carrier L; Bercovici J; Cruaud C; Richard P; Hainque B; Gautel M; Labeit S; James M; Beckmann J; Weissenbach J; Vosberg HP; Fiszman M; Komajda M; Schwartz K
Nat Genet; 1995 Dec; 11(4):438-40. PubMed ID: 7493026
[TBL] [Abstract][Full Text] [Related]
8. Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.
Bing W; Redwood CS; Purcell IF; Esposito G; Watkins H; Marston SB
Biochem Biophys Res Commun; 1997 Jul; 236(3):760-4. PubMed ID: 9245729
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of hypertrophic cardiomyopathy.
Marian AJ; Roberts R
Annu Rev Med; 1995; 46():213-22. PubMed ID: 7598458
[TBL] [Abstract][Full Text] [Related]
10. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.
Niimura H; Patton KK; McKenna WJ; Soults J; Maron BJ; Seidman JG; Seidman CE
Circulation; 2002 Jan; 105(4):446-51. PubMed ID: 11815426
[TBL] [Abstract][Full Text] [Related]
11. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
[TBL] [Abstract][Full Text] [Related]
12. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
Redwood CS; Moolman-Smook JC; Watkins H
Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy.
Palmiter KA; Solaro RJ
Basic Res Cardiol; 1997; 92 Suppl 1():63-74. PubMed ID: 9202846
[TBL] [Abstract][Full Text] [Related]
14. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
Kamisago M; Sharma SD; DePalma SR; Solomon S; Sharma P; McDonough B; Smoot L; Mullen MP; Woolf PK; Wigle ED; Seidman JG; Seidman CE
N Engl J Med; 2000 Dec; 343(23):1688-96. PubMed ID: 11106718
[TBL] [Abstract][Full Text] [Related]
15. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.
Lin D; Bobkova A; Homsher E; Tobacman LS
J Clin Invest; 1996 Jun; 97(12):2842-8. PubMed ID: 8675696
[TBL] [Abstract][Full Text] [Related]
16. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
[TBL] [Abstract][Full Text] [Related]
18. Sarcomeric protein mutations in dilated cardiomyopathy.
Chang AN; Potter JD
Heart Fail Rev; 2005 Sep; 10(3):225-35. PubMed ID: 16416045
[TBL] [Abstract][Full Text] [Related]
19. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.
Golitsina N; An Y; Greenfield NJ; Thierfelder L; Iizuka K; Seidman JG; Seidman CE; Lehrer SS; Hitchcock-DeGregori SE
Biochemistry; 1997 Apr; 36(15):4637-42. PubMed ID: 9109674
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
Kimura A; Harada H; Park JE; Nishi H; Satoh M; Takahashi M; Hiroi S; Sasaoka T; Ohbuchi N; Nakamura T; Koyanagi T; Hwang TH; Choo JA; Chung KS; Hasegawa A; Nagai R; Okazaki O; Nakamura H; Matsuzaki M; Sakamoto T; Toshima H; Koga Y; Imaizumi T; Sasazuki T
Nat Genet; 1997 Aug; 16(4):379-82. PubMed ID: 9241277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
